Naratriptan

CAS No. 121679-13-8

Naratriptan( —— )

Catalog No. M22535 CAS No. 121679-13-8

Naratriptan is a selective agonist of 5-HT1 receptor and is is used for the treatment of migraine headaches.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 63 In Stock
10MG 88 In Stock
25MG 160 In Stock
50MG 240 In Stock
100MG 361 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Naratriptan
  • Note
    Research use only, not for human use.
  • Brief Description
    Naratriptan is a selective agonist of 5-HT1 receptor and is is used for the treatment of migraine headaches.
  • Description
    Naratriptan is a selective agonist of 5-HT1 receptor and is is used for the treatment of migraine headaches.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT1
  • Research Area
    Nervous system
  • Indication
    Psychotic Disorders|Antisocial Personality Disorder|Impulse Regulation Disorder|Intermittent Explosive Disorder

Chemical Information

  • CAS Number
    121679-13-8
  • Formula Weight
    333.45
  • Molecular Formula
    C17H23N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ito Y , Mitsufuji T , Asano Y , et al. Naratriptan in the Prophylactic Treatment of Cluster Headache[J]. Intern Med, 2017, 56(19).
molnova catalog
related products
  • SB1317

    SB1317 is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).

  • Cerlapirdine

    Cerlapirdine is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine is already in clinical development for the treatment of cognitive disorders related to Alzheimer's disease and schizophrenia. It works by acting as a selective 5-HT6 receptor antagonist.

  • Lasmiditan hydrochlo...

    Lasmiditan hydrochloride is a novel centrally acting highly selective 5-HT(1F) receptor agonist (K1:2.21 μM).